» Articles » PMID: 26491231

Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2015 Oct 23
PMID 26491231
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Oxygen homeostasis reflects the constant body requirement to generate energy. Hypoxia (0.1-1% O2), physioxia or physoxia (∼1-13%), and normoxia (∼20%) are terms used to define oxygen concentration in the cellular environment. A decrease in oxygen (hypoxia) or excess oxygen (hyperoxia) could be deleterious for cellular adaptation and survival. Hypoxia can occur under both physiological (e.g., exercise, embryonic development, underwater diving, or high altitude) and pathological conditions (e.g., inflammation, solid tumor formation, lung disease, or myocardial infarction). Hypoxia plays a key role in the pathophysiology of heart disease, cancers, stroke, and other causes of mortality. Hypoxia inducible factor(s) (HIFs) are key oxygen sensors that mediate the ability of the cell to cope with decreased oxygen tension. These transcription factors regulate cellular adaptation to hypoxia and protect cells by responding acutely and inducing production of endogenous metabolites and proteins to promptly regulate metabolic pathways. Here, we review the role of the HIF pathway as a metabolic adaptation pathway and how this pathway plays a role in cell survival. We emphasize the roles of the HIF pathway in physiological adaptation, cell death, pH regulation, and adaptation during exercise.

Citing Articles

L-Arginine and Nitric Oxide in Vascular Regulation-Experimental Findings in the Context of Blood Donation.

Kurhaluk N, Tkaczenko H Nutrients. 2025; 17(4).

PMID: 40004994 PMC: 11858268. DOI: 10.3390/nu17040665.


Glial Cell Reprogramming in Ischemic Stroke: A Review of Recent Advancements and Translational Challenges.

Gresita A, Hermann D, Boboc I, Doeppner T, Petcu E, Semida G Transl Stroke Res. 2025; .

PMID: 39904845 DOI: 10.1007/s12975-025-01331-7.


Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?.

Forkan C, Shrestha A, Yu A, Chuang C, Pociot F, Yarani R Stem Cell Res Ther. 2025; 16(1):37.

PMID: 39901225 PMC: 11792614. DOI: 10.1186/s13287-025-04153-4.


Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes.

Parvaneh S, Miklos V, Pahi Z, Szucs D, Monostori T, Poliska S Int J Mol Sci. 2025; 26(1.

PMID: 39796244 PMC: 11720846. DOI: 10.3390/ijms26010390.


Current Advances and Future Directions of Pluripotent Stem Cells-Derived Engineered Heart Tissue for Treatment of Cardiovascular Diseases.

He X, Good A, Kalou W, Ahmad W, Dutta S, Chen S Cells. 2025; 13(24).

PMID: 39768189 PMC: 11674482. DOI: 10.3390/cells13242098.


References
1.
Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter K, Harris A, Koukourakis M . Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res. 2003; 13(5):493-501. DOI: 10.1097/00008390-200310000-00008. View

2.
Peng Y, Nanduri J, Khan S, Yuan G, Wang N, Kinsman B . Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci U S A. 2011; 108(7):3065-70. PMC: 3041114. DOI: 10.1073/pnas.1100064108. View

3.
Barak V, Peer J, Kalickman I, Frenkel S . VEGF as a biomarker for metastatic uveal melanoma in humans. Curr Eye Res. 2011; 36(4):386-90. DOI: 10.3109/02713683.2010.534573. View

4.
Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington K, Edwards L . Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A. 2010; 107(28):12722-7. PMC: 2906567. DOI: 10.1073/pnas.1002339107. View

5.
Marti H, Katschinski D, Wagner K, Schaffer L, Stier B, Wenger R . Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Mol Endocrinol. 2002; 16(2):234-43. DOI: 10.1210/mend.16.2.0786. View